Alpine Immune Sciences Inc (ALPN)
N/A x N/A N/A x N/A
Post-market by (Cboe BZX)
64.97 +0.01 (+0.02%) 05/17/24 [NASDAQ]
N/A x N/A N/A x N/A
Post-market 64.97 unch (unch) -
for Fri, May 17th, 2024
Results
download Want to compare other data? Select FieldsSymbol | ALPN | IONS | SLNO | ||
Company | Alpine Immune Sciences Inc | Ionis Pharmaceuticals | Soleno Therapeutics Inc | ||
Price Information | |||||
Exchange | NASDAQ | NASDAQ | NASDAQ | ||
Open | 64.98 | 28.31 | 69.96 | ||
High | 65.00 | 28.76 | 70.51 | ||
Low | 64.97 | 28.04 | 68.34 | ||
Last | 64.97 | 28.40 | 69.98 | ||
Change | +0.01 | +0.05 | +0.05 | ||
% Change | +0.02% | +0.18% | +0.07% | ||
Volume | 4,288,300 | 842,600 | 1,236,200 | ||
20-Day Average Volume | 1,891,270 | 1,981,665 | 2,600,915 | ||
Previous Close | 64.96 | 28.35 | 69.93 | ||
Industry | Medical - Drugs | Medical - Drugs | Medical - Drugs | ||
Has Options | No | Yes | Yes | ||
Technicals | |||||
20-Day Moving Average | 64.72 | 29.20 | 64.64 | ||
20-Day Raw Stochastic | 94.64% | 45.36% | 84.98% | ||
20-Day Relative Strength | 80.75% | 43.93% | 61.96% | ||
Weighted Alpha | +232.23 | -35.74 | +49.41 | ||
Today's Opinion | 100% Buy | 100% Sell | 100% Buy | ||
Previous Opinion | 100% Buy | 100% Sell | 100% Buy | ||
Last Month's Opinion | 100% Buy | 40% Sell | 32% Sell | ||
Performance | |||||
5-Days | |||||
%Chg | +0.05% since 05/10/24 | +6.33% since 04/10/25 | +11.31% since 04/10/25 | ||
Low | 64.92 on 05/13/24 | 26.30 on 04/11/25 | 62.11 on 04/11/25 | ||
High | 65.00 on 05/17/24 | 29.04 on 04/14/25 | 71.00 on 04/16/25 | ||
1-Month | |||||
%Chg | +0.79% since 04/17/24 | -17.20% since 03/17/25 | +41.00% since 03/17/25 | ||
Low | 64.40 on 04/19/24 | 23.95 on 04/09/25 | 47.23 on 03/21/25 | ||
High | 65.00 on 05/17/24 | 34.13 on 03/18/25 | 74.00 on 04/03/25 | ||
3-Month | |||||
%Chg | +107.84% since 02/16/24 | -9.64% since 01/17/25 | +49.27% since 01/17/25 | ||
Low | 29.56 on 02/21/24 | 23.95 on 04/09/25 | 43.00 on 03/11/25 | ||
High | 65.00 on 05/17/24 | 35.31 on 01/27/25 | 74.00 on 04/03/25 | ||
6-Month | |||||
%Chg | +385.58% since 11/17/23 | -26.21% since 10/17/24 | +30.80% since 10/17/24 | ||
Low | 13.30 on 11/21/23 | 23.95 on 04/09/25 | 41.50 on 01/15/25 | ||
High | 65.00 on 05/17/24 | 40.58 on 10/29/24 | 74.00 on 04/03/25 | ||
Key Statistics | |||||
Market Capitalization, $K | 4,456,812 | 4,514,606 | 3,209,073 | ||
Shares Outstanding, K | 68,598 | 158,965 | 45,857 | ||
Annual Sales | 58,880,000 | 705,140,000 | 0 | ||
Annual Net Income | -32,180,000 | -453,900,000 | -175,850,000 | ||
Last Quarter Sales | 7,030,000 | 226,580,000 | 0 | ||
Last Quarter Net Income | -17,920,000 | -104,350,000 | -55,980,000 | ||
60-Month Beta | 0.97 | 0.29 | -2.29 | ||
Per-Share Information | |||||
Most Recent Earnings | -0.28 on 05/09/24 | -0.66 on 02/19/25 | -1.27 on 02/27/25 | ||
Latest Earnings Date | 05/09/24 | 04/30/25 | 05/08/25 | ||
Most Recent Dividend | N/A | N/A | N/A | ||
Next Ex-Dividends Date | N/A | N/A | N/A | ||
Ratios | |||||
Price/Earnings ttm | 0.00 | 0.00 | 0.00 |